Carcinogenic risks of inorganic arsenic in perspective

International Archives of Occupational and Environmental Health

Volumn 68, Issue 6, 1996, Pages 484-494

  Byrd, Daniel M ^a   Luann Roegner, M ^a   Griffiths, James C ^b   Lamm, Steven H ^c   Grumski, Karen S ^c   Wilson, Richard ^d   Lai, Shenghan ^e  

^a Risk Assessment and Product Safety ^*  (United States)

^b INTERNATIONAL SPECIALTY PRODUCTS   (United States)

^c Epidemiology and Occupational Health Inc   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DRINKING WATER;

CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; INGESTION; INHALATION; LUNG CANCER; SKIN CANCER; SPECIES; SPECIES DIFFERENCE; TARGET ORGAN; WATER SUPPLY;

EID: 10144235823     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00377874     Document Type: Conference Paper

References (51)

1. Chen C-J, Wang CJ (1990) Ecological correction between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 550: 5470-5474
2. Lamm SH, Lederer WH (1985) Inorganic arsenic: The importance of accurate exposure characterization in risk assessment. In: Risk analysis in the private sector. Whipple C, Covello VT (eds) Plenum Press, New York, pp 149-163
3. International Agency For Research on Cancer, IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, Vol. 23, Some metals and metallic compounds. World Health Organization, Lyon, France (1980)
4. Petito CT, Beck BD (1991) Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis. Trace Subst Environ Health 24: 143-176
5. Bates MN, et al. (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135: 462-476
6. Smith TJ, et al. (1977) Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ Health Persp 19: 89-93
7. Chakraborty AK, Saha KC (1987) Arsenical dermatoses from tubewell water in west Bengal. Ind J Med Res 85: 326-334
8. Tsuda T, et al. (1995) Ingested arsenic and internal cancer: a historical cohort followed for 33 years. Am J Epidemiol 141: 198-209
9. Cebrian ME, et al. (1983) Chronic arsenic poisoning in the north of Mexico. Human Toxicol 2: 121-133
10. Lou Z-D, et al. (1995) Chronic Arsenicism and Cancer in Inner Mongolia -Consequences of Arsenic in Deep Wells. J Environ Geochem Health (in press)
11. Zalvidar R (1974) Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning. Bitrage Pathologica 151: 384-400
12. Tseng WP, et al. (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Nat Cancer Inst 40: 453-463
13. Chen C-J, et al. (1988) Atherogenicity and carcinogenicity of high arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8: 452-460
14. Chang T-C, et al. (1991) Higher prevalence of goiter in endemic area of blackfoot disease of Taiwan. J Formosan Med Assoc 90: 941-946
15. Lu J-N, Chen C-J (1991) Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res 11: 229-234
16. Wu M-M, et al. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130: 1123-1132
17. Fierz VU (1965) Katamnestische Untersuchungen über die Nebenwirkungen der Therapie mit anorganischem Arsen bei Hautkrankheiten. Dermatologica 131: 41-58
18. Goldsmith JR (1972) Evaluation of health implications of elevated arsenic in well water. Water Res 6: 1133-1136
19. Harrington JM, et al. (1978) A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am J Epidemiol 108: 377-385
20. Southwick JW, et al. (1983) An epidemiological study of arsenic in drinking water in Millard County, Utah. In: Lederer WH, Fensterheim RJ (eds) Arsenic: industrial, biomedical, environmental perspectives. Van Nostrand Reinhold, New York, pp 210-225
21. Tay C-H, Seah C-S (1975) Arsenic poisoning from anti-asthmatic herbal preparations. Med J Austria 2: 424-428
22. Armitage P, Doll R (1961) Stochastic models for carcinogenesis. In: Neyman J (ed) Proceedings of the Fourth Berkeley Symposium on mathematical statistics and probability 4: 19-38
23. Crump KS, et al. (1976) Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res 36: 2973-2979
24. Crump KS, et al. (1977) Confidence intervals and tests of hypothesis concerning dose response relations inferred from animal carcinogenicity data. Biometrics 33: 437-451
25. Lu FJ (1990) Blackfoot disease: arsenic or humic acid? Lancet 336: 115-116
26. Lin SM, Yang MH (1988) Arsenic, selenium, and zinc in patients with blackfoot disease. Biol Trace Elem Res 15: 213-221
27. Pontius FW, et al. (1994) Health implications of arsenic in drinking water. J Am Water Works Assoc, September: pp 52-63
28. Vahter M (1983) Metabolism of arsenic, In: Fowler BA (ed) Biological and Environmental Effects of Arsenic. Elsevier Science Press, New York
29. Vahter M, Marafante E (1985) Reduction and binding of arsenate in Marmoset monkeys. Arch Toxicol 57: 119-124
30. 73As by whole-body autoradiography in mice. J Toxicol Environ Health 1: 981-984
31. 74As-Arsenite or Arsenate. Acta Pharmacol Toxicolog 51: 253-265
32. Jung C, Rothstein A, (1965) Arsenate uptake and release in relation to the inhibition of transport and glycolysis in yeast. Biochem Pharmacol 14: 1093-1112
33. McKinney JD. (1992) Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health 14: 43-48
34. Thomas DJ (1994) Arsenic toxicity in humans: research problems and prospects. Environ Geochem Health 16: 107-111
35. Thompson DJ (1993) A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interactions 88: 89-114
36. Endo G, et al. (1992) Dimethylarsenic acid induces tetraploids in Chinese hamster cells. Bull Environ Contamin Toxicol 48: 131-137
37. Shirachi DY, et al. (1983) Tumorigenic effect of sodium arsenite in rat kidney. Proceeding of the Western Pharmacology Society 26: 413-415
38. Yamamoto S, et al. (1995) Cancer induction by an organic arsenic compound, dimethylarsenic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res 55: 1271-1276
39. Yamanaka K, et al. (1991) Cellular response to oxidative damage in lung induced by the administration of dimethylarsenic acid, a major metabolite of inorganic arsenics, in mice. Toxicol Appl Pharmacol 108: 205-213
40. Vahter M, Envall J (1983) In vivo reduction of arsenate in mice and rabbits. Environ Res 32: 14-24
41. Marcus WL, Rispin AS (1988) Threshold carcinogenicity using arsenic as an example. In: Cothern CR, Mehlman MA, Marcus WL (eds) Risk Assessment and Risk Management of Industrial and Environmental Chemicals. Princeton Scientific, N.J., pp 133-158
42. Valentine JL, Kang HK, Spivey G (1979) Arsenic levels in human blood, urine, and hair in response to exposure via drinking water. Environ Res 20: 24-31
43. Brown CC, Chu KC (1983) Implications of the multistage theory of carcinogenesis applied to occupational arsenic exposure. J Nat Cancer Ins 70: 455-463
44. Jacobson-Kram D, Montalbano D (1985) The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic. Environ Mutagen 7: 787-804
45. Lee T-C, et al. (1985) Comparison of arsenic-induced cell transformation, cytotoxicity, mutation, and cytogenic effects in Syrian hamster embryo cells in culture. Carcinogenesis 6: 1421-1426
46. Bauman JW, Liu J, Klaassen CD (1993) Production of metal-lothionine and heat shock proteins by metals. Fundam Appl Toxicol 21: 15-22
47. Moolgavkar SH (1991) Carcinogenesis models: an overview. Bas Life Sci 58: 387-96
48. Vig BK, et al. (1984) Chromosome studies in human subjects chronically exposed to arsenic in drinking water. Am J Ind Med 6: 325-338
49. Brown KG, Chen C-J (1994) On the observed dose-response for internal cancers and arsenic in drinking water in the Blackfoot disease endemic region of Taiwan. In: Arsenic: exposure and health. Chappell WR, Abernathy CO, Cothern CR, (eds) First International Conference on Arsenic Exposure and Health Effects. Sci Technol Lett, Northwood, England, pp 153-169
50. Brown KG, Chen C-J (1995) Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Analysis Vol. 15: 475-484
51. Smith AH, et al. (1992) Cancer risks from arsenic in drinking water. Environ Health Persp 97: 259-267